Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 88, Issue 1, Pages 41-55
Publisher
Wiley
Online
2010-04-02
DOI
10.1189/jlb.1009671
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis
- (2014) S. Shahrara et al. JOURNAL OF IMMUNOLOGY
- Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection
- (2014) G. T. Schnickel et al. JOURNAL OF IMMUNOLOGY
- Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to Atherosclerosis
- (2009) Emmanuel L. Gautier et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Retracted: CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice
- (2009) J. Li et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Plerixafor
- (2009) Antona J. Wagstaff DRUGS
- Chemokine receptor antagonists: part 2
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemokine receptor antagonists: Part 1
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- An Engineered GM-CSF-CCL2 Fusokine Is a Potent Inhibitor of CCR2-Driven Inflammation As Demonstrated in a Murine Model of Inflammatory Arthritis
- (2009) M. Rafei et al. JOURNAL OF IMMUNOLOGY
- Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice
- (2009) Daniël Eefting et al. JOURNAL OF VASCULAR SURGERY
- Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
- (2009) Joshua S Hunt et al. PHARMACOTHERAPY
- Safety concerns about CCR5 as an antiviral target
- (2009) Amalio Telenti Current Opinion in HIV and AIDS
- Monocyte-Mediated Defense Against Microbial Pathogens
- (2008) Natalya V. Serbina et al. Annual Review of Immunology
- A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
- (2008) Vincent Braunersreuther et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
- (2008) Christophe Combadière et al. CIRCULATION
- A Deletion in the Chemokine Receptor 5(CCR5)Gene Is Associated with Tickborne Encephalitis
- (2008) Elin Kindberg et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic Deficiency of Chemokine Receptor CCR5 Is a Strong Risk Factor for Symptomatic West Nile Virus Infection: A Meta‐Analysis of 4 Cohorts in the US Epidemic
- (2008) Jean K. Lim et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant Model
- (2008) Jeffrey D. Alexis et al. JOURNAL OF VASCULAR RESEARCH
- Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
- (2007) Antonella Viola et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started